Stephen Hahn is the founder of Harbinger Health. Harbinger Health has raised $190M in total funding. Latest round: Series B. Backed by Flagship Pioneering.
Stephen Hahn is the founder and CEO of Harbinger Health, a cancer diagnostic firm focused on early cancer identification through blood-based screening tests. He previously served as the Commissioner of the U.S. Food and Drug Administration (FDA) from 2019 to 2021 before joining Flagship Pioneering to lead Harbinger Health. The company launched a 10,000-participant clinical study in 2022 to validate its early-cancer test.
Full founder directory · Investor directory · Company funding database · Fundraising library